Phase 1, Single Dose Study to evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

Trial Identifier: D7870C00001
Sponsor: MedImmune, LLC
NCTID:: NCT03001297
Start Date: January 2017
Primary Completion Date: August 2018
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Japanese Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206